VFX.AX Visionflex Fpo ASX A$0.096 intraday 19 Feb 2026: Oversold bounce to A$0.20

VFX.AX stock trades at A$0.096 in intraday trade on 19 Feb 2026, showing a thin-volume bounce after recent weakness. This oversold bounce setup looks technical rather than fundamental: volume is only 52.00 shares versus a 50-day average of 17,401.00, and the 50-day average price sits at A$0.09688. Investors watching small-cap healthcare names should note the gap between the near-term trading price and Meyka AI’s longer-term model forecasts. We summarise the technical trigger, valuation data, and a practical risk template for traders considering an oversold bounce in Visionflex Fpo (VFX.AX) on the ASX.

VFX.AX stock intraday snapshot

Price is A$0.096 with a 1-day change of -1.03% and a market capitalisation of A$8,309,989.00. Day range is locked at A$0.096 and liquidity is extremely low with volume 52.00 versus average volume 17,401.00, which heightens execution risk.

VFX.AX stock technicals and oversold signals

Short-term technicals show an oversold context: the stock sits near its 50-day average A$0.09688 and well above its year low of A$0.05, but below the year high A$0.15. Low volume and a high ADX of 71.43 indicate a strong directional move recently; for an oversold bounce trade we watch a break above A$0.11 on improving volume as a validation trigger.

VFX.AX stock fundamentals and valuation

Visionflex Fpo reports EPS -0.05 and a trailing PE of -1.92, reflecting negative earnings. Price-to-sales is 1.79 while book metrics show negative book value per share at -0.03, signalling weak balance-sheet equity.

Meyka AI rates VFX.AX with a score out of 100

Meyka AI rates VFX.AX with a score of 66.57 out of 100 (Grade B, suggestion: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The score balances short-term technical opportunity against stretched fundamentals and low liquidity.

Meyka AI’s forecast and price targets for VFX.AX stock

Meyka AI’s forecast model projects a 1-year target of A$0.38013 and a quarterly level of A$0.20. Compared with the current price A$0.096, the model implies an upside of about 296.00% to the 1-year forecast and a nearer-term upside of 108.33% to A$0.20. Forecasts are model-based projections and not guarantees.

Trade strategy and risk for VFX.AX stock oversold bounce

An oversold bounce trade on VFX.AX should be size-limited due to extremely low liquidity and volatile bid-ask spreads. Use a tight validation entry above A$0.11 on volume and consider a protective stop near A$0.06 to limit downside; that stop implies potential downside of about -37.50% from A$0.096. This is analysis, not personalised advice, and traders should weigh execution costs and sector risk.

Final Thoughts

Key takeaway: VFX.AX stock sits in an intraday oversold bounce setup on 19 Feb 2026 with price A$0.096, low volume 52.00, and clear technical thresholds. Short-term traders can target a near-term bounce to A$0.20 (quarterly model) while longer-term model projection from Meyka AI is A$0.38013, an implied upside of 296.00% versus the current price. Fundamentals remain weak: EPS -0.05, PE -1.92, negative book value, and tight cash metrics increase risk that any rebound is short lived. Sector context is mixed — healthcare peers trade higher PE multiples and stronger liquidity — so a disciplined trade plan with precise entry, volume confirmation, and a protective stop is essential. Meyka AI, as an AI-powered market analysis platform, highlights this as a high-volatility, high-risk opportunity; forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.